drugset / Trial / NCT00642161

New Version Pulmicort Turbuhaler USA Children

NCT00642161 ↗

Phase 3 Completed 430 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

A comparison of the safety, efficacy and budesonide pharmacokinetics of the currently approved Pulmicort Turbuhaler with a new version of the inhaler, in children and adolescents who have asthma. In addition the study evaluated the functionality of the new inhaler at the end of its intended life.

Timeline

Start
2002-11
Primary completion
2004-09
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule — —

Indications